Ryan Cohlhepp

Leading biotech executive with over 20 years of expertise in driving early-stage drug development to commercial success. Ryan Cohlhepp founding executive of Rheos Medicines, an immuno-metabolism company launched from Third Rock Ventures. He is

responsible for Takeda’s commercial oncology portfolio in the US that included four compounds across a range of both hematological and solid tumors. Ryan holds a Pharm.D. in Pharmacy from Purdue University and current member of the Dean’s Advisory Council.